Consolidated Condensed Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash Flows from Operating Activities
Net income	$ 3,261.3	$ 3,489.5
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:
Depreciation and amortization	1,117.6	1,054.7
Changes in deferred income taxes	206.2	222.0
Stock-based compensation expense	100.3	110.7
Impairment charges, indefinite lived intangibles	16.0	151.0
Acquired in-process research and development, net of tax	0	252.2
Income related to prepayment of revenue-sharing obligation	(787.8)	0
Other changes in operating assets and liabilities	(271.5)	76.7
Other operating activities, net	60.7	(67.0)
Net Cash Provided by Operating Activities	3,702.8	5,289.8
Cash Flows from Investing Activities
Net purchases of property and equipment	(492.2)	(416.1)
Net change in short-term investments	257.3	545.0
Proceeds from sales and maturities of noncurrent investments	3,557.4	1,082.6
Purchases of noncurrent investments	(5,506.8)	(2,659.3)
Purchase of product rights	(102.0)	(605.7)
Purchase of in-process research and development	0	388.0
Cash paid for acquisitions, net of cash acquired	(199.3)	(307.8)
Net change in loan to collaboration partner	165.0	(165.0)
Proceeds from prepayment of revenue-sharing obligation	1,212.1	0
Other investing activities, net	(61.8)	(33.3)
Net Cash Used for Investing Activities	(1,170.3)	(2,947.6)
Cash Flows from Financing Activities
Dividends paid	(1,639.2)	(1,636.2)
Net change in short-term borrowings	(15.2)	(28.6)
Repayment of long-term debt	(1,500.0)	(54.6)
Other financing activities, net	0	0.4
Net Cash Used for Financing Activities	(3,154.4)	(1,719.0)
Effect of exchange rate changes on cash and cash equivalents	18.6	(18.7)
Net (decrease) increase in cash and cash equivalents	(603.3)	604.5
Cash and cash equivalents at January 1	5,922.5	5,993.2
Cash and Cash Equivalents at September 30	$ 5,319.2	$ 6,597.7